Differential Impact of Recruited and Resident Macrophages on Hypoxia-Induced Pulmonary Hypertension
- 30 January 2026
- journal article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 138 (3)
Abstract
BACKGROUND: Pulmonary interstitial macrophages can be divided into 2 distinct subsets with different origins: resident macrophages (resMФs) and recruited macrophages (recMФs). However, their specific roles in pulmonary arterial hypertension remain unclear. METHODS: Bone marrow transplantation, the DT (diphtheria toxin) receptor system, and genetically modified murine models were utilized to explore how key TFs (transcription factors) regulate phenotype alterations in pulmonary resMФs and recMФs in an SU5416/hypoxia murine model of pulmonary hypertension (PH). Therapeutic approaches included DNA aptamer–based proteolysis-targeting chimera and small interfering RNA–loaded lipid nanoparticle for treating SU5416/hypoxia–exposed rats. RESULTS: Depletion of either resMФs or recMФs using DT treatment significantly reduced SU5416/hypoxia–induced PH in mice. Pulmonary recMФs exhibited a proinflammatory phenotype during PH, driven by the TF Hic1 (hypermethylated in cancer 1). Bone marrow transplantation with Hic1 −/− recMФs ameliorated PH in mice. Hic1 enhanced proinflammatory gene transcription by inhibiting Sirt1 (sirtuin 1)-mediated H3K9ac (histone H3 lysine 9 acetylation) deacetylation in the promoter regions. In contrast, pulmonary resMФs demonstrated a profibrotic transcriptome characterized by upregulation of MMP genes that are, in turn, regulated by Prrx2 (paired-related homeobox 2). Prrx2 deletion in resMФs protected against PH in mice by reducing perivascular fibrosis. Simultaneously targeting Prrx2 and Hic1 in macrophages significantly alleviated SU5416/hypoxia–induced PH in rats. CONCLUSIONS: The differential roles of pulmonary resMФs and recMФs in pulmonary vascular remodeling highlight novel therapeutic targets for pulmonary arterial hypertension treatment, specifically through inhibition of Hic1 and Prrx2 in macrophages.Keywords
This publication has 102 references indexed in Scilit:
- Targeted liposomes for macrophages-mediated pulmonary fibrosis therapyDrug Delivery and Translational Research, 2024
- The evolution of survival of pulmonary arterial hypertension over 15 yearsPulmonary Circulation, 2022
- Biology of lung macrophages in health and diseaseImmunity, 2022
- Prrx1 Fibroblasts Represent a Pro-fibrotic Lineage in the Mouse Ventral DermisCell Reports, 2020
- Tissue-Specific Macrophage Responses to Remote Injury Impact the Outcome of Subsequent Local Immune ChallengeImmunity, 2019
- Origin and production of inflammatory perivascular macrophages in pulmonary hypertensionCytokine, 2017
- PRRX1- and PRRX2-positive mesenchymal stem/progenitor cells are involved in vasculogenesis during rat embryonic pituitary developmentCell and tissue research, 2015
- Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under HomeostasisImmunity, 2013
- Generation of two modified mouse alleles of the Hic1 tumor suppressor geneGenesis, 2011
- Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage ResponsesCell, 2005